Anti-CD19 BiTE (R) blinatumomab induces high complete remission rates in adult patients with relapsed/refractory B-precursor acute lymphoblastic leukaemia (ALL) including relapse after stem cell transplantation (SCT)

Topp, M. and Goekbuget, N. and Zugmaier, G. and Viardot, A. and Stelljes, M. and Neumann, S. and Horst, H. A. and Reichle, A. and Marks, R. and Faul, C. and Brueggemann, M. and Ritgen, M. and Klappers, P. and Mergen, N. and Goebeler, M. -E. and Einsele, H. and Hoelzer, D. and Bargou, R. (2013) Anti-CD19 BiTE (R) blinatumomab induces high complete remission rates in adult patients with relapsed/refractory B-precursor acute lymphoblastic leukaemia (ALL) including relapse after stem cell transplantation (SCT). BONE MARROW TRANSPLANTATION, 48 (Suppl2). S40-S41. ISSN 0268-3369

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 02 Jun 2020 05:46
Last Modified: 02 Jun 2020 05:46
URI: https://pred.uni-regensburg.de/id/eprint/16868

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.